Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2021-04, Vol.84 (4), p.1098-1100
Hauptverfasser:	Mahmoudi, Hamidreza, Farid, Ali Salehi, Nili, Ali, Dayani, Dorsa, Tavakolpour, Soheil, Soori, Tahereh, Teimourpour, Amir, Isazade, Ahdie, Abedini, Robabeh, Balighi, Kamran, Daneshpazhooh, Maryam
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Inflammatory Agents - therapeutic use Autoimmune Diseases - drug therapy COVID-19 - epidemiology Female Hospitalization - statistics & numerical data Humans Immunologic Factors - therapeutic use Iran - epidemiology Male Middle Aged Prednisolone - therapeutic use Prognosis Research Letter Retrospective Studies Risk Factors Rituximab - therapeutic use SARS-CoV-2 Skin Diseases, Vesiculobullous - drug therapy Skin Diseases, Vesiculobullous - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!